Trial Profile
Exposure-response relationship of BMS 936557 in patients with moderate-to-severe ulcerative colitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Eldelumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 09 Mar 2011 New trial record